Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Hyperhidrosis, Malaise, Pain in extremity, Peripheral coldness, Pyrexia
Clinical narrative: trouble walking; her head felt really hot; her hands felt really cold; her upper arm sore; headache; her temperature was not very high; Sweats; she really did not feel good; chills; aching in her joints; This spontaneous case was reported by a patient and describes the occurrence of HYPERHIDROSIS (Sweats), MALAISE (she really did not feel good), GAIT DISTURBANCE (trouble walking), FEELING HOT (her head felt really hot) and PERIPHERAL COLDNESS (her hands felt really cold) in a 72-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 053022A) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below.     Previously administered products included for Drug use for unknown indication: Pfizer COVID-19 vaccine (1st dose, lot number: ER8727) on 18-Mar-2021, Pfizer COVID-19 vaccine (2nd dose, lot number: ER8729) on 08-Apr-2021, Pfizer COVID-19 vaccine (1st booster dose and lot number: FU162C) on 16-Mar-2022. Past adverse reactions to the above products included No adverse event with Pfizer COVID-19 vaccine, Pfizer COVID-19 vaccine and Pfizer COVID-19 vaccine. Concomitant products included LISINOPRIL and METFORMIN for an unknown indication.    On 19-Oct-2022, the patient received fourth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. On 19-Oct-2022, the patient experienced HYPERHIDROSIS (Sweats), MALAISE (she really did not feel good), CHILLS (chills) and ARTHRALGIA (aching in her joints). On 20-Oct-2022, the patient experienced GAIT DISTURBANCE (trouble walking), FEELING HOT (her head felt really hot), PERIPHERAL COLDNESS (her hands felt really cold) and HEADACHE (headache). 20-Oct-2022, the patient experienced PAIN IN EXTREMITY (her upper arm sore) and PYREXIA (her temperature was not very high). The patient was treated with ACETYLSALICYLIC ACID (BABY ASPIRIN) at an unspecified dose and frequency. At the time of the report, HYPERHIDROSIS (Sweats), MALAISE (she really did not feel good), GAIT DISTURBANCE (trouble walking), FEELING HOT (her head felt really hot), PERIPHERAL COLDNESS (her hands felt really cold), PAIN IN EXTREMITY (her upper arm sore), CHILLS (chills), ARTHRALGIA (aching in her joints), HEADACHE (headache) and PYREXIA (her temperature was not very high) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: (Negative) Negative.     For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter did not provide any causality assessments.   The patient had no allergies and no acute and chronic illnesses at the time of vaccination. The patient was not given any other vaccines within 1 month prior to Moderna COVID-19 vaccine. The patient had never had COVID + test or diagnosis.  On 19-Oct-2022, the patient received the booster dose of Moderna COVID-19 vaccine, Bivalent. The patient took 5 Baby Aspirins.